Monogram Biosciences, Inc. 4/A
4/A · Monogram Biosciences, Inc. · Filed Jan 22, 2009
Insider Transaction Report
Form 4/AAmended
Parry Gordon
VP, R & D Oncology
Transactions
- Award
Stock Option (Rt to Buy)
2009-01-16+40,000→ 40,000 totalExercise: $2.41From: 2010-01-16Exp: 2017-01-15→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the stock option shall vest and become exercisable on January 16, 2010. Thereafter, the remaining option shares shall vest and become exercisable in thirty-six (36) equal consecutive monthly installments until all of the option shares become vested.
- [F2]This amended Form 4 is being filed to correct the vesting schedule applicable to this option grant.